Louise Ramhøj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Louise Ramhøj has a total of 157 co-authors. Here are the top co-authors by number of shared publications:
- Terje Svingen
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
19 shared publications Marta Axelstad
National Food Institute, Technical University of Denmark, Kongens Lyngby, Denmark
12 shared publications- Marta Axelstad
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
7 shared publications Bertrand Evrard
Université de Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085 , Rennes F-35000
5 shared publications- Josef Köhrle
Charité-Universitätsmedizin Berlin
4 shared publications - Sofie Christiansen
National Food Institute, Technical University of Denmark, Kgs. Lyngby, Denmark
4 shared publications
Latest Publications
- 17 November 2026
- Published by Springer Nature in Nature Reviews Endocrinology
Protecting brain development from thyroid hormone system-disrupting chemicals
- 17 November 2026
- Published by Springer Nature in Nature Reviews Endocrinology
Protecting brain development from thyroid hormone system-disrupting chemicals
- Open Access
- 31 October 2026
- Published by Springer Nature in Archives of Toxicology
- p. 1-22
Testing strategy for the identification of thyroid hormone system disrupting chemicals
- 31 October 2026
- Published by Springer Nature in Archives of Toxicology
- p. 1-22
Open AccessTesting strategy for the identification of thyroid hormone system disrupting chemicals
- Open Access
- 25 August 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (12) , 5717-5731
PFAS: challenges and scientific perspectives in human health risk assessment
To review recent advances in research on per- and polyfluoroalkyl substances (PFAS) and outline priority steps for risk assessment in consumer health protection, the German Federal Institute for Risk Assessment (BfR) organized the ‘International PFAS Conference’ in Berlin in October 2025. Building on the European Food Safety Authority's (EFSA) opinion in 2020, global research activities on PFAS have intensified. The conference was attended by 200 participants from 18 countries and covered topics such as analytical methods, human exposure, toxicokinetics, toxicity, and future perspectives. Given that there are more than 21,000 different PFAS in use, discussions highlighted the need for further data collection and a basis for prioritizing substances. Robust exposure assessment requires improved analytical methods combined with newly developed predictive tools to quantify, identify, and make better use of non-target data. Hazard characterization may benefit from the combined use of classic experimental data sets, epidemiological data, and new approach methodologies (NAMs) data. The participants emphasized the continuous need for refined data and proposed a systematic consolidation of global data on shared data platforms, accompanied by corresponding guidelines for data usage. In the final panel discussion, effective risk communication was identified as a critical challenge, necessitating clear and consistent messaging for the public and policymakers. The conference concluded with five key recommendations for future health risk assessments: prioritizing PFAS; improving analytical methods; promoting generation of robust data and data gap filling; promoting open science, including the development of shared data infrastructure and cross-institutional knowledge exchange; and strengthening risk communication. These recommendations aim to support transparent, evidence-based and effective PFAS consumer health risk management in the decades ahead.
- 25 August 2026
- Published by Springer Nature in Archives of Toxicology
- Vol. 100 (12) , 5717-5731
Open AccessPFAS: challenges and scientific perspectives in human health risk assessment
To review recent advances in research on per- and polyfluoroalkyl substances (PFAS) and outline priority steps for risk assessment in consumer health protection, the German Federal Institute for Risk Assessment (BfR) organized the ‘International PFAS Conference’ in Berlin in October 2025. Building on the European Food Safety Authority's (EFSA) opinion in 2020, global research activities on PFAS have intensified. The conference was attended by 200 participants from 18 countries and covered topics such as analytical methods, human exposure, toxicokinetics, toxicity, and future perspectives. Given that there are more than 21,000 different PFAS in use, discussions highlighted the need for further data collection and a basis for prioritizing substances. Robust exposure assessment requires improved analytical methods combined with newly developed predictive tools to quantify, identify, and make better use of non-target data. Hazard characterization may benefit from the combined use of classic experimental data sets, epidemiological data, and new approach methodologies (NAMs) data. The participants emphasized the continuous need for refined data and proposed a systematic consolidation of global data on shared data platforms, accompanied by corresponding guidelines for data usage. In the final panel discussion, effective risk communication was identified as a critical challenge, necessitating clear and consistent messaging for the public and policymakers. The conference concluded with five key recommendations for future health risk assessments: prioritizing PFAS; improving analytical methods; promoting generation of robust data and data gap filling; promoting open science, including the development of shared data infrastructure and cross-institutional knowledge exchange; and strengthening risk communication. These recommendations aim to support transparent, evidence-based and effective PFAS consumer health risk management in the decades ahead.
- Open Access
- 12 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1823237
Maternal exposure to the thyroperoxidase-inhibiting pesticide amitrole induces hypothyroidism and developmental neurotoxicity in the rat brain
Thyroid hormone (TH) system-disrupting chemicals pose significant risks to human health and the environment, highlighting the urgent need for improved toxicological testing methods. A major concern is that environmental chemicals may induce developmental neurotoxicity by compromising TH signaling during critical life stages. In this study, we evaluated the thyroidal and neurotoxic effects of two compounds that interfere with TH signaling by inhibiting TH synthesis in the thyroid gland. Methimazole (MMI) is a pharmaceutical specifically designed to treat hyperthyroidism by inhibiting thyroperoxidase (TPO), while the herbicide amitrole has unintentional TPO-inhibiting properties. Pregnant and lactating rat dams were exposed to control (corn oil), 8 or 16 mg/kg body weight/day MMI, or 25 or 50 mg/kg body weight/day amitrole from gestation day 7 to postnatal day 16. MMI and amitrole induced fetal and postnatal hypothyroidism in offspring. Both compounds induced similar reductions in serum and brain TH concentrations and induced a brain malformation, periventricular heterotopia, tied to compromised TH signaling. Our results reinforce concerns over the potential for exposure to environmental chemicals with TH system-disrupting properties to negatively impact the developing brain in vertebrates.
- 12 May 2026
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 17, 1823237
Open AccessMaternal exposure to the thyroperoxidase-inhibiting pesticide amitrole induces hypothyroidism and developmental neurotoxicity in the rat brain
Thyroid hormone (TH) system-disrupting chemicals pose significant risks to human health and the environment, highlighting the urgent need for improved toxicological testing methods. A major concern is that environmental chemicals may induce developmental neurotoxicity by compromising TH signaling during critical life stages. In this study, we evaluated the thyroidal and neurotoxic effects of two compounds that interfere with TH signaling by inhibiting TH synthesis in the thyroid gland. Methimazole (MMI) is a pharmaceutical specifically designed to treat hyperthyroidism by inhibiting thyroperoxidase (TPO), while the herbicide amitrole has unintentional TPO-inhibiting properties. Pregnant and lactating rat dams were exposed to control (corn oil), 8 or 16 mg/kg body weight/day MMI, or 25 or 50 mg/kg body weight/day amitrole from gestation day 7 to postnatal day 16. MMI and amitrole induced fetal and postnatal hypothyroidism in offspring. Both compounds induced similar reductions in serum and brain TH concentrations and induced a brain malformation, periventricular heterotopia, tied to compromised TH signaling. Our results reinforce concerns over the potential for exposure to environmental chemicals with TH system-disrupting properties to negatively impact the developing brain in vertebrates.
- Open Access
- 24 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (2)
Transcriptomic profiling reveals thyroid hormone-mediated and compound-specific effects of methimazole and amitrole on testis development
Thyroid hormones (THs) influence testis development, with early life hypothyroidism resulting in smaller testes. Developmental exposure to thyroperoxidase (TPO)-inhibiting drugs such as propylthiouracil (PTU) and methimazole (MMI) also impair testis development in rodents by reducing TH levels, leading to smaller testes in pups due to, for instance, disrupted Sertoli cell proliferation and maturation. Comparable effects are seen following exposure to the TPO-inhibiting pesticide amitrole, one of many environmental chemicals with TH-disrupting properties. Despite this phenotype, the molecular underpinnings of hypothyroid-induced testis effects are less clear, complicating mechanism-based chemical toxicity testing relying on alternative test methods and omics approaches. Here, we report on transcriptomics profiling of testes from hypothyroid rats induced by chemical exposures. Pregnant Sprague-Dawley rat dams were exposed by oral gavage to 2 doses of MMI (8 or 16 mg/kg body weight/day) or amitrole (25 or 50 mg/kg bw/day) from gestational day (GD) 7 to pup day (PD) 16, with BRB-seq performed for both life stages, specifically GD21 and PD16. Both MMI and amitrole caused significant changes to the testis transcriptome, seen particularly at PD16, with 313 differentially expressed genes (DEGs) defining a shared TH-mediated profile. Additionally, amitrole exposure resulted in a distinct profile of 1,517 DEGs, suggesting compound-specific effects beyond TH disruption. This study underscores the potential sensitivity of transcriptomic profiling in detecting early tissue disruption under toxicological conditions, in this case, testis disruption under hypothyroid state, offering critical insights for chemical risk assessment beyond histopathological endpoints.
- 24 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (2)
Open AccessTranscriptomic profiling reveals thyroid hormone-mediated and compound-specific effects of methimazole and amitrole on testis development
Thyroid hormones (THs) influence testis development, with early life hypothyroidism resulting in smaller testes. Developmental exposure to thyroperoxidase (TPO)-inhibiting drugs such as propylthiouracil (PTU) and methimazole (MMI) also impair testis development in rodents by reducing TH levels, leading to smaller testes in pups due to, for instance, disrupted Sertoli cell proliferation and maturation. Comparable effects are seen following exposure to the TPO-inhibiting pesticide amitrole, one of many environmental chemicals with TH-disrupting properties. Despite this phenotype, the molecular underpinnings of hypothyroid-induced testis effects are less clear, complicating mechanism-based chemical toxicity testing relying on alternative test methods and omics approaches. Here, we report on transcriptomics profiling of testes from hypothyroid rats induced by chemical exposures. Pregnant Sprague-Dawley rat dams were exposed by oral gavage to 2 doses of MMI (8 or 16 mg/kg body weight/day) or amitrole (25 or 50 mg/kg bw/day) from gestational day (GD) 7 to pup day (PD) 16, with BRB-seq performed for both life stages, specifically GD21 and PD16. Both MMI and amitrole caused significant changes to the testis transcriptome, seen particularly at PD16, with 313 differentially expressed genes (DEGs) defining a shared TH-mediated profile. Additionally, amitrole exposure resulted in a distinct profile of 1,517 DEGs, suggesting compound-specific effects beyond TH disruption. This study underscores the potential sensitivity of transcriptomic profiling in detecting early tissue disruption under toxicological conditions, in this case, testis disruption under hypothyroid state, offering critical insights for chemical risk assessment beyond histopathological endpoints.
- Open Access
- 22 November 2025
- Published by Elsevier in Toxicology
- Vol. 520, 154353
In vitro and in vivo thyroid hormone system disruption by perfluorooctane sulfonate (PFOS) and tetrabromobisphenol A (TBBPA)
- 22 November 2025
- Published by Elsevier in Toxicology
- Vol. 520, 154353
Open AccessIn vitro and in vivo thyroid hormone system disruption by perfluorooctane sulfonate (PFOS) and tetrabromobisphenol A (TBBPA)
- Open Access
- 14 October 2024
- Published by Elsevier in Environmental Pollution
- Vol. 363 (Pt 1) , 125117
Perinatal exposure to environmental chemicals that disrupt thyroid function can perturb testis development
- 14 October 2024
- Published by Elsevier in Environmental Pollution
- Vol. 363 (Pt 1) , 125117
Open AccessPerinatal exposure to environmental chemicals that disrupt thyroid function can perturb testis development
- Open Access
- 27 April 2024
- Published by Elsevier in Toxicology
- Vol. 505, 153822
Two thyroperoxidase-inhibiting chemicals induce shared transcriptional changes in hippocampus of developing rats
- 27 April 2024
- Published by Elsevier in Toxicology
- Vol. 505, 153822
Open AccessTwo thyroperoxidase-inhibiting chemicals induce shared transcriptional changes in hippocampus of developing rats
- Open Access
- 14 July 2023
- Published by Elsevier in Environmental Pollution
- Vol. 334, 122179
Antibiotic induced restructuring of the gut microbiota does not affect oral uptake and accumulation of perfluorooctane sulfonic acid (PFOS) in rats
- 14 July 2023
- Published by Elsevier in Environmental Pollution
- Vol. 334, 122179
Open AccessAntibiotic induced restructuring of the gut microbiota does not affect oral uptake and accumulation of perfluorooctane sulfonic acid (PFOS) in rats
- Open Access
- 4 July 2023
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 142, 105445
Is periventricular heterotopia a useful endpoint for developmental thyroid hormone system disruption in mouse toxicity studies?
- 4 July 2023
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 142, 105445
Open AccessIs periventricular heterotopia a useful endpoint for developmental thyroid hormone system disruption in mouse toxicity studies?